Literature DB >> 22808695

Health characteristics of Medicare traditional fee-for-service and Medicare Advantage enrollees: 1999-2004 National Health and Nutrition Examination Survey linked to 2007 Medicare data.

Lisa B Mirel1, Gloria Wheatcroft, Jennifer D Parker, Diane M Makuc.   

Abstract

BACKGROUND: National Health and Nutrition Examination Survey (NHANES) records have been linked to health care use and expenditure information from Medicare records. Claims data are generally available only for traditional fee-for-service (FFS) enrollees and not for Medicare Advantage enrollees. Differences in health characteristics between Medicare Advantage and traditional FFS enrollees could affect conclusions from analyses of the linked files that are restricted to traditional FFS enrollees.
METHODS: Data from the 1999-2004 NHANES linked to the 2007 Medicare enrollment data were analyzed. Using examination and interview data collected in NHANES, we compared health characteristics of Medicare beneficiaries aged 65 and over at the NHANES interview by their type of Medicare enrollment in 2007.
RESULTS: We found that the overall percentage of Medicare beneficiaries who had hypertension at the time of the NHANES medical examination was lower for Medicare Advantage enrollees compared with traditional FFS enrollees; this was found for the non-Hispanic white population but not for other race and ethnicity groups. We found no statistically significant differences between Medicare Advantage and traditional FFS enrollees overall or within race and ethnicity groups for other health characteristics that were measured or reported at the time of the NHANES interview or medical examination in 1999-2004.
CONCLUSIONS: Despite finding no large differences in health characteristics by Medicare enrollment in this analysis, users of the National Center for Health Statistics Medicare linked files should consider potential differences in health characteristics between Medicare Advantage and traditional FFS enrollees that could influence results limited to traditional FFS beneficiaries only.

Entities:  

Mesh:

Year:  2012        PMID: 22808695

Source DB:  PubMed          Journal:  Natl Health Stat Report        ISSN: 2164-8344


  5 in total

1.  Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.

Authors:  Gabriel S Tajeu; Shia T Kent; Ian M Kronish; Lei Huang; Marie Krousel-Wood; Adam P Bress; Daichi Shimbo; Paul Muntner
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

2.  Association of falls with health-related quality of life (HRQOL) in older cancer survivors: A population based study.

Authors:  Chintan Pandya; Allison Magnuson; William Dale; Lisa Lowenstein; Chunkit Fung; Supriya G Mohile
Journal:  J Geriatr Oncol       Date:  2016-02-18       Impact factor: 3.599

3.  The Impact of Enhanced Critical Care Training and 24/7 (Tele-ICU) Support on Medicare Spending and Postdischarge Utilization Patterns.

Authors:  Matthew J Trombley; Andrea Hassol; Jennifer T Lloyd; Timothy G Buchman; Allison F Marier; Alan White; Erin Colligan
Journal:  Health Serv Res       Date:  2017-12-27       Impact factor: 3.402

4.  Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.

Authors:  Mark A Hlatky; Roberta M Ray; Dale R Burwen; Karen L Margolis; Karen C Johnson; Anna Kucharska-Newton; JoAnn E Manson; Jennifer G Robinson; Monika M Safford; Matthew Allison; Themistocles L Assimes; Anthony A Bavry; Jeffrey Berger; Rhonda M Cooper-DeHoff; Susan R Heckbert; Wenjun Li; Simin Liu; Lisa W Martin; Marco V Perez; Hilary A Tindle; Wolfgang C Winkelmayer; Marcia L Stefanick
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-01-07

5.  Diabetes Prevalence and Incidence Among Medicare Beneficiaries - United States, 2001-2015.

Authors:  Linda J Andes; Yanfeng Li; Meera Srinivasan; Stephen R Benoit; Edward Gregg; Deborah B Rolka
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-01       Impact factor: 17.586

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.